Targeted treatments for lung cancer and urological cancers

Description: This course provides a broad overview of the cells, genes, proteins and pathways that drive non-small cell lung cancer (NSCLC), prostate cancer and kidney cancer. The course includes the rationale behind many different targeted treatment approaches in use and in development for these cancers, including recent advances in immunotherapies for lung, prostate, kidney and bladder cancer.
Level: Advanced
To book, contact: conferenceteam@rmh.nhs.uk
View the programme
For further information, including costs, visit the Royal Marsden website